Back to results

TerminatedPhase 2

Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)

NCT02368691

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Holy Cross Hospital

Fort Lauderdale, Florida, United States

+6 additional locations

View on ClinicalTrials.gov